• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

物质使用障碍经济评估的货币转换因素。

Monetary conversion factors for economic evaluations of substance use disorders.

机构信息

Department of Public Health Sciences, University of Miami Miller School of Medicine, Soffer Clinical Research Center, Suite 1019, 1120 NW 14th Street, Miami, FL 33136, USA.

Department of Sociology and Health Economics Research Group, University of Miami, 5665 Ponce de Leon Boulevard, Flipse Building, Room 122, P.O. Box 248251, Coral Gables, FL 33124, USA.

出版信息

J Subst Abuse Treat. 2017 Oct;81:25-34. doi: 10.1016/j.jsat.2017.07.008. Epub 2017 Jul 18.

DOI:10.1016/j.jsat.2017.07.008
PMID:28847452
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5654317/
Abstract

AIMS

Estimating the economic consequences of substance use disorders (SUDs) is important for evaluating existing programs and new interventions. Policy makers in particular must weigh program effectiveness with scalability and sustainability considerations in deciding which programs to fund with limited resources. This study provides a comprehensive list of monetary conversion factors for a broad range of consequences, services, and outcomes, which can be used in economic evaluations of SUD interventions (primarily in the United States), including common co-occurring conditions such as HCV and HIV.

METHODS

Economic measures were selected from standardized clinical assessment instruments that are used in randomized clinical trials and other research studies (e.g., quasi-experimental community-based projects) to evaluate the impact of SUD interventions. National datasets were also reviewed for additional SUD-related consequences, services, and outcomes. Monetary conversion factors were identified through a comprehensive literature review of published articles as well as targeted searches of other sources such as government reports.

RESULTS

Eight service/consequence/outcome domains were identified containing more than sixty monetizable measures of medical and behavioral health services, laboratory services, SUD treatment, social services, productivity outcomes, disability outcomes, criminal activity and criminal justice services, and infectious diseases consequences. Unit-specific monetary conversion factors are reported, along with upper and lower bound estimates, whenever possible.

CONCLUSIONS

Having an updated and standardized source of monetary conversion factors will facilitate and improve future economic evaluations of interventions targeting SUDs and other risky behaviors. This exercise should be repeated periodically as new sources of data become available to maintain the timeliness, comprehensiveness, and quality of these estimates.

摘要

目的

评估物质使用障碍 (SUD) 的经济后果对于评估现有方案和新干预措施非常重要。政策制定者必须权衡方案的有效性、可扩展性和可持续性,以有限的资源决定为哪些方案提供资金。本研究提供了一系列广泛的后果、服务和结果的货币转换因素,可用于 SUD 干预措施的经济评估(主要在美国),包括常见的共病如 HCV 和 HIV。

方法

经济措施选自标准化的临床评估工具,这些工具用于随机临床试验和其他研究研究(例如,准实验性社区基础项目),以评估 SUD 干预措施的影响。还审查了国家数据集,以获取其他与 SUD 相关的后果、服务和结果。通过对已发表文章的全面文献回顾以及对政府报告等其他来源的有针对性搜索,确定了货币转换因素。

结果

确定了八个服务/后果/结果领域,其中包含六十多种可货币化的医疗和行为健康服务、实验室服务、SUD 治疗、社会服务、生产力结果、残疾结果、犯罪活动和刑事司法服务以及传染病后果的衡量指标。尽可能报告了特定于单位的货币转换因素,以及上限和下限估计值。

结论

拥有最新和标准化的货币转换因素来源将有助于并改善未来针对 SUD 和其他危险行为的干预措施的经济评估。随着新数据源的出现,应定期重复此操作,以保持这些估计的及时性、全面性和质量。

相似文献

1
Monetary conversion factors for economic evaluations of substance use disorders.物质使用障碍经济评估的货币转换因素。
J Subst Abuse Treat. 2017 Oct;81:25-34. doi: 10.1016/j.jsat.2017.07.008. Epub 2017 Jul 18.
2
Economic benefits of substance use disorder treatment: A systematic literature review of economic evaluation studies from 2003 to 2021.物质使用障碍治疗的经济效益:2003 年至 2021 年经济评估研究的系统文献回顾。
J Subst Use Addict Treat. 2023 Sep;152:209084. doi: 10.1016/j.josat.2023.209084. Epub 2023 Jun 9.
3
Unit Costs of Delinquent Acts for Use in Economic Evaluations.经济评估中使用的违规行为单位成本。
J Ment Health Policy Econ. 2019 Jun 1;22(2):71-79.
4
A research agenda for economic evaluation of substance abuse services.药物滥用服务经济评估的研究议程。
J Subst Abuse Treat. 2005 Sep;29(2):125-37. doi: 10.1016/j.jsat.2005.05.009.
5
Cost-Effectiveness and Affordability of Interventions, Policies, and Platforms for the Prevention and Treatment of Mental, Neurological, and Substance Use Disorders预防和治疗精神、神经及物质使用障碍的干预措施、政策和平台的成本效益及可负担性
6
A legal dispute resolution intervention for patients with substance use disorders: a study protocol for a randomized controlled trial.物质使用障碍患者的法律纠纷解决干预:一项随机对照试验的研究方案。
BMC Public Health. 2023 Mar 6;23(1):435. doi: 10.1186/s12889-023-15296-5.
7
Guidelines and challenges for estimating the economic costs and benefits of adolescent substance abuse treatments.青少年药物滥用治疗经济成本与效益评估的指导方针及挑战
J Subst Abuse Treat. 2005 Oct;29(3):191-205. doi: 10.1016/j.jsat.2005.06.004.
8
Using the DATCAP and ASI to estimate the costs and benefits of residential addiction treatment in the State of Washington.使用药物成瘾治疗成本及效益量表(DATCAP)和成瘾严重程度指数(ASI)来评估华盛顿州住院成瘾治疗的成本和效益。
Soc Sci Med. 2002 Dec;55(12):2267-82. doi: 10.1016/s0277-9536(02)00060-6.
9
A Cost-Effectiveness Analysis of Stop Smoking Interventions in Substance-Use Disorder Populations.物质使用障碍人群戒烟干预的成本效益分析。
Nicotine Tob Res. 2019 Apr 17;21(5):623-630. doi: 10.1093/ntr/nty087.
10
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.

引用本文的文献

1
Study assessing the effectiveness of overdose prevention centers through research (SAFER): an overview of the study protocol.通过研究评估过量用药预防中心有效性的研究(SAFER):研究方案概述
Harm Reduct J. 2025 May 13;22(Suppl 1):76. doi: 10.1186/s12954-025-01211-1.
2
Cost and cost-effectiveness of abstinence-contingent wage supplements for adults experiencing homelessness and alcohol use disorder.为无家可归且患有酒精使用障碍的成年人提供基于戒酒的工资补贴的成本及成本效益
J Subst Use Addict Treat. 2025 Feb;169:209569. doi: 10.1016/j.josat.2024.209569. Epub 2024 Nov 9.
3
The substance use disorder treatment gap among US college students: Findings from the 2021 National Survey on Drug Use and Health.美国大学生物质使用障碍治疗差距:2021年全国药物使用和健康调查结果
Drug Alcohol Depend Rep. 2024 Aug 30;12:100279. doi: 10.1016/j.dadr.2024.100279. eCollection 2024 Sep.
4
Yoga and Physical Therapy for Chronic Pain and Opioid Use Disorder Onsite in an Opioid Treatment Program: A Randomized Controlled Trial.阿片类药物治疗项目中针对慢性疼痛和阿片类药物使用障碍的现场瑜伽与物理治疗:一项随机对照试验
Subst Use Addctn J. 2025 Jan;46(1):175-183. doi: 10.1177/29767342241265929. Epub 2024 Aug 1.
5
Health care use and cost of treatment for adolescents and young adults with opioid use disorder.青少年和青年成人群体中阿片类药物使用障碍的治疗保健使用和费用。
J Subst Use Addict Treat. 2023 Nov;154:209137. doi: 10.1016/j.josat.2023.209137. Epub 2023 Aug 7.
6
Cost and cost-effectiveness of abstinence contingent wage supplements.基于戒除的工资补贴的成本和成本效益。
Drug Alcohol Depend. 2023 Mar 1;244:109754. doi: 10.1016/j.drugalcdep.2022.109754. Epub 2022 Dec 23.
7
Navigation Services to Avoid Rehospitalization among Medical/Surgical Patients with Comorbid Substance Use Disorder: Rationale and Design of a Randomized Controlled Trial.针对患有合并物质使用障碍的内科/外科患者避免再次住院的导航服务:一项随机对照试验的原理与设计
J Psychiatr Brain Sci. 2020;5(3). doi: 10.20900/jpbs.20200013. Epub 2020 Jun 12.
8
Cost and Cost Savings of Navigation Services to Avoid Rehospitalization for a Comorbid Substance Use Disorder Population.导航服务避免共病物质使用障碍人群再住院的成本和成本节约。
Med Care. 2022 Aug 1;60(8):631-635. doi: 10.1097/MLR.0000000000001743. Epub 2022 Jun 10.
9
Complementary and Alternative Medicine for Substance Use Disorders: A Scientometric Analysis and Visualization of Its Use Between 2001 and 2020.物质使用障碍的补充与替代医学:2001年至2020年期间其应用的科学计量分析与可视化
Front Psychiatry. 2021 Nov 5;12:722240. doi: 10.3389/fpsyt.2021.722240. eCollection 2021.
10
Cost and Cost-Effectiveness of Incentives for Viral Suppression in People Living with HIV.激励艾滋病毒感染者抑制病毒的成本和成本效益。
AIDS Behav. 2022 Mar;26(3):795-804. doi: 10.1007/s10461-021-03439-x. Epub 2021 Aug 26.

本文引用的文献

1
Lifetime risk of a diagnosis of HIV infection in the United States.美国艾滋病毒感染诊断的终生风险。
Ann Epidemiol. 2017 Apr;27(4):238-243. doi: 10.1016/j.annepidem.2017.02.003. Epub 2017 Feb 21.
2
Adjusting Health Expenditures for Inflation: A Review of Measures for Health Services Research in the United States.调整卫生支出的通货膨胀率:美国卫生服务研究的措施述评。
Health Serv Res. 2018 Feb;53(1):175-196. doi: 10.1111/1475-6773.12612. Epub 2016 Nov 21.
3
Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine.《健康与医疗领域成本效益分析的实施、方法学实践和报告推荐:第二版》。
JAMA. 2016 Sep 13;316(10):1093-103. doi: 10.1001/jama.2016.12195.
4
The Economic Burden of Prescription Opioid Overdose, Abuse, and Dependence in the United States, 2013.2013年美国处方阿片类药物过量、滥用及成瘾的经济负担
Med Care. 2016 Oct;54(10):901-6. doi: 10.1097/MLR.0000000000000625.
5
The Opioid Epidemic: AMA's response.阿片类药物流行:美国医学协会的应对措施。
Am Fam Physician. 2016 Jun 15;93(12):975.
6
2010 National and State Costs of Excessive Alcohol Consumption.2010年过量饮酒造成的国家和州成本。
Am J Prev Med. 2015 Nov;49(5):e73-e79. doi: 10.1016/j.amepre.2015.05.031. Epub 2015 Oct 1.
7
Data Collection and Harmonization in HIV Research: The Seek, Test, Treat, and Retain Initiative at the National Institute on Drug Abuse.艾滋病病毒研究中的数据收集与整合:美国国立药物滥用研究所的“寻找、检测、治疗和保留”倡议
Am J Public Health. 2015 Dec;105(12):2416-22. doi: 10.2105/AJPH.2015.302788. Epub 2015 Oct 15.
8
Cost of Screening, Brief Intervention, and Referral to Treatment in Health Care Settings.医疗保健机构中筛查、简短干预及转介治疗的成本
J Subst Abuse Treat. 2016 Jan;60:54-61. doi: 10.1016/j.jsat.2015.06.005. Epub 2015 Jun 18.
9
The lifetime medical cost savings from preventing HIV in the United States.在美国,预防艾滋病病毒所节省的终身医疗费用。
Med Care. 2015 Apr;53(4):293-301. doi: 10.1097/MLR.0000000000000308.
10
Updating cost-effectiveness--the curious resilience of the $50,000-per-QALY threshold.更新成本效益——每质量调整生命年5万美元阈值令人好奇的韧性。
N Engl J Med. 2014 Aug 28;371(9):796-7. doi: 10.1056/NEJMp1405158.